Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular membrane phospholipid headgroups are the hydrophilic moieties of phospholipids that define the surface chemistry of biological membranes. These groups, including phosphatidylserine (PS), phosphatidylcholine (PC), and phosphatidylethanolamine (PE), play vital roles in membrane stability, vesicle trafficking, and cell signaling (Birge et al., 2016, Cell Death & Differentiation). Under physiological conditions, the distribution of these headgroups is asymmetric; for instance, PS is sequestered in the inner leaflet by flippases. However, in pathological states such as apoptosis or malignancy, PS is exposed on the outer leaflet, where it serves as a marker for phagocytic clearance and contributes to an immunosuppressive environment (DeRose et al., 2011, Immunotherapy). This phenomenon is exploited therapeutically by agents like bavituximab, which targets exposed PS to stimulate anti-tumor immune responses (Gerber et al., 2015, Clinical Cancer Research). Furthermore, specific headgroups in microbial membranes, such as phosphatidylglycerol, are targeted by antibiotics like daptomycin to disrupt membrane integrity and cause cell death (Silverman et al., 2003, Antimicrobial Agents and Chemotherapy). The recognition of these headgroups by the immune system is also a key factor in autoimmune conditions like antiphospholipid syndrome (Schreiber et al., 2018, Nature Reviews Disease Primers). Additionally, certain viruses utilize host membrane phospholipids for fusion and entry, making these headgroups potential targets for broad-spectrum antivirals.
Binding to specific phospholipid headgroups to induce immune-mediated cell clearance, disrupt microbial membrane integrity, or inhibit viral entry (Birge et al., 2016, Cell Death & Differentiation; Silverman et al., 2003, Antimicrobial Agents and Chemotherapy).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membrane phospholipid headgroups.